Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood
Marcelo Comerlato Scottá, Renato T. Stein
Jornal de Pediatria (2022) Vol. 99, pp. S4-S11
Open Access | Times Cited: 19

Showing 19 citing articles:

Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
Lessandra Michelin, Nancy Bellei, Marcelo Ferreira da Costa Gomes, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Hospitalization for bronchiolitis in children aged ≤ 1year, Southern Italy, year 2021: need for new preventive strategies?
Maria Elisabetta Baldassarre, Daniela Loconsole, Francesca Centrone, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2023) Vol. 49, Iss. 1
Open Access | Times Cited: 11
Identifying Gaps and Opportunities for Maternal and Neonatal Immunization Research and Implementation in Latin America
Marco Aurélio Palazzi Sáfadi, Edwin J. Asturias, Mercedes Colomar, et al.
The Pediatric Infectious Disease Journal (2025) Vol. 44, Iss. 2S, pp. S18-S22
Closed Access
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice
Daniela Ogonczyk-Makowska, Pauline Brun, Clémence Vacher, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Multicenter study to describe viral etiologies, clinical profiles, and outcomes of hospitalized children with severe acute respiratory infections, Egypt 2022
Amr Kandeel, Manal Fahim, Ola Deghedy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
COPD Pathogenesis and Alterations in the Oral, Lung, and Gut Microbiomes
Nobuhiro Asai, Yoshihiro Ohkuni, Hideo Kato, et al.
Microbiology Research (2024) Vol. 15, Iss. 3, pp. 1605-1615
Open Access | Times Cited: 2
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach
Marina Antillón, Xiao Li, Lander Willem, et al.
PLoS Medicine (2023) Vol. 20, Iss. 7, pp. e1004250-e1004250
Open Access | Times Cited: 6
Management of pneumonia and pleural effusion in children
Laura Menestrino Prestes, Miguel Ângelo Uflacker Lutz de Castro, Gabriela de Azevedo Bastian de Souza, et al.
Jornal Brasileiro de Pneumologia (2023), pp. e20230370-e20230370
Open Access | Times Cited: 4
Estrategias y recomendaciones para enfrentar la enfermedad por virus respiratorio sincicial el año 2024
Enrique Paris, Paula Daza, Lorena Tapia, et al.
Andes pediatrica (2024) Vol. 95, Iss. 1, pp. 17-17
Open Access | Times Cited: 1


Acta Pediátrica de México (2024) Vol. 45, Iss. 4
Open Access | Times Cited: 1
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue
Qianqian Li, Huan Li, Zhihua Li, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 1
Exploring the adoption of less restricted criteria for respiratory syncytial virus prophylaxis in late preterm infants: insights from a retrospective analysis
Vito Mondı̀, Piermichele Paolillo, Manuela Bedetta, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 2
The importance of immunization as a public health instrument
Marco Aurélio Palazzi Sáfadi
Jornal de Pediatria (2022) Vol. 99, pp. S1-S3
Open Access | Times Cited: 4
Situación actual de las vacunas atenuadas intranasales frente al virus respiratorio sincitial en la población infantil
Jordi Reina, Andrés Suárez
Vacunas (2024) Vol. 25, Iss. 1, pp. 140-146
Closed Access
Current situation of intranasal attenuated vaccines against respiratory syncytial virus in the child population
Jordi Reina, Andrés Suárez
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 140-146
Closed Access
Seasonality of the incidence of bronchiolitis in infants — Brazil, 2016–2022: An interrupted time-series analysis
Frederico Friedrich, Magali Santos Lumertz, Lucas Montiel Petry, et al.
Revista Paulista de Pediatria (2024) Vol. 43
Open Access
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
Matteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1317-1317
Open Access
New mucosal bivalent live-attenuated vaccine is protective against Human Metapneumovirus and Respiratory Syncytial Virus
Julia Dubois, Daniela Ogonczyk-Makowska, Clémence Vacher, et al.
Research Square (Research Square) (2023)
Open Access
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use
Matt Shirley
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 12, pp. 413-420
Closed Access
Page 1

Scroll to top